PRESS RELEASES

Featured post

January 13, 2025

Exact Sciences Announces Preliminary Fourth Quarter 2024 Results

Exact Sciences Announces Preliminary Fourth Quarter 2024 Results

Read more »

Featured post

December 02, 2024

Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening

Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening

Read more »

Featured post

November 25, 2024

Exact Sciences Advances Breast Cancer Care with the Oncotype DX^® test and Genomic Profiling Research at SABCS 2024

Exact Sciences Advances Breast Cancer Care with the Oncotype DX^® test and Genomic Profiling Research at SABCS 2024

Read more »

March 17, 2021

JAMIE FOXX, STAND UP TO CANCER AND EXACT SCIENCES LAUNCH PSA TO INCREASE AWARENESS OF COLORECTAL CANCER
February 10, 2021

The Truth About Cancer: Debunking Five Myths about the Big C
December 17, 2020

$10 MILLION GRANT FROM EXACT SCIENCES TO SUPPORT STAND UP TO CANCER INITIATIVE TO IMPROVE COLORECTAL CANCER SCREENING AND PREVENTION
December 11, 2020

New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice
December 09, 2020

RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer
November 02, 2020

Exact Sciences Mourns the Death of Dr. David Ahlquist, a Pioneer in Early Cancer Detection
October 28, 2020

Exact Sciences Commends Task Force for Draft Updated Guidelines that include Colorectal Cancer Screening Beginning at Age 45
October 12, 2020

Exact Sciences Introduces the Oncotype MAP™ Pan-Cancer Tissue Test to Help Guide Treatment for Patients with Advanced Cancer
June 16, 2020

Oncotype DX Genomic Prostate Score® Result Shows for the First Time the Value of the Test to Guide Treatment Plans for Unfavorable Intermediate-Risk Prostate Cancer Patients
May 29, 2020

Exact Sciences Showcases Continued Progress in Cancer Diagnostics at ASCO 2020
May 14, 2020

New Oncotype DX® Real-world Evidence Shows for the First Time the Practice-changing Impact of TAILORx Results
May 05, 2020

New Model Shared at Digestive Disease Week (DDW) Demonstrates the Value of Cologuard® When Using Real-World Adherence Rates for Comparing Colorectal Cancer Screening Methods

Choose your country

Patient login

Provider login

Choose your country

PRESS RELEASES

Exact Sciences Announces Preliminary Fourth Quarter 2024 Results

Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening

Exact Sciences Advances Breast Cancer Care with the Oncotype DX^® test and Genomic Profiling Research at SABCS 2024

JAMIE FOXX, STAND UP TO CANCER AND EXACT SCIENCES LAUNCH PSA TO INCREASE AWARENESS OF COLORECTAL CANCER

The Truth About Cancer: Debunking Five Myths about the Big C

$10 MILLION GRANT FROM EXACT SCIENCES TO SUPPORT STAND UP TO CANCER INITIATIVE TO IMPROVE COLORECTAL CANCER SCREENING AND PREVENTION

New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice

RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer

Exact Sciences Mourns the Death of Dr. David Ahlquist, a Pioneer in Early Cancer Detection

Exact Sciences Commends Task Force for Draft Updated Guidelines that include Colorectal Cancer Screening Beginning at Age 45

Exact Sciences Introduces the Oncotype MAP™ Pan-Cancer Tissue Test to Help Guide Treatment for Patients with Advanced Cancer

Oncotype DX Genomic Prostate Score® Result Shows for the First Time the Value of the Test to Guide Treatment Plans for Unfavorable Intermediate-Risk Prostate Cancer Patients

Exact Sciences Showcases Continued Progress in Cancer Diagnostics at ASCO 2020

New Oncotype DX® Real-world Evidence Shows for the First Time the Practice-changing Impact of TAILORx Results

New Model Shared at Digestive Disease Week (DDW) Demonstrates the Value of Cologuard® When Using Real-World Adherence Rates for Comparing Colorectal Cancer Screening Methods

Multimedia

Choose your country

Patient login

Provider login

Choose your country

PRESS RELEASES

Exact Sciences Announces Preliminary Fourth Quarter 2024 Results

Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening

Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024

JAMIE FOXX, STAND UP TO CANCER AND EXACT SCIENCES LAUNCH PSA TO INCREASE AWARENESS OF COLORECTAL CANCER

The Truth About Cancer: Debunking Five Myths about the Big C

$10 MILLION GRANT FROM EXACT SCIENCES TO SUPPORT STAND UP TO CANCER INITIATIVE TO IMPROVE COLORECTAL CANCER SCREENING AND PREVENTION

New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice

RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer

Exact Sciences Mourns the Death of Dr. David Ahlquist, a Pioneer in Early Cancer Detection

Exact Sciences Commends Task Force for Draft Updated Guidelines that include Colorectal Cancer Screening Beginning at Age 45

Exact Sciences Introduces the Oncotype MAP™ Pan-Cancer Tissue Test to Help Guide Treatment for Patients with Advanced Cancer

Oncotype DX Genomic Prostate Score® Result Shows for the First Time the Value of the Test to Guide Treatment Plans for Unfavorable Intermediate-Risk Prostate Cancer Patients

Exact Sciences Showcases Continued Progress in Cancer Diagnostics at ASCO 2020

New Oncotype DX® Real-world Evidence Shows for the First Time the Practice-changing Impact of TAILORx Results

New Model Shared at Digestive Disease Week (DDW) Demonstrates the Value of Cologuard® When Using Real-World Adherence Rates for Comparing Colorectal Cancer Screening Methods

Multimedia

Quick links

Products and services

Science

About

News and events

Exact Sciences Advances Breast Cancer Care with the Oncotype DX^® test and Genomic Profiling Research at SABCS 2024